Cytochrome P450 isoforms are differently up-regulated in aflatoxin B1-exposed human lymphocytes and monocytes

Immunopharmacology and Immunotoxicology

Volumn 36, Issue 1, 2014, Pages 1-10

  Bahari, Abbas ^a   Mehrzad, Jalil ^a   Mahmoudi, Mahmoud ^b   Bassami, Mohammad Reza ^a   Dehghani, Hesam ^a  

^a FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aflatoxin B1; CYP; Lymphocytes; Monocytes; QPCR; Toll like receptor 4

Indexed keywords

AFLATOXIN B1; COMPLEMENTARY DNA; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYTOCHROME P450 3A7; ISOPROTEIN; TOLL LIKE RECEPTOR 4;

ARTICLE; CELL CYCLE; CELL STRAIN HEPG2; DNA SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOTOXICITY; IN VITRO STUDY; LYMPHOCYTE; MALE; MONOCYTE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADOLESCENT; ADULT; AFLATOXIN B1; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEP G2 CELLS; HUMANS; ISOENZYMES; LYMPHOCYTES; MALE; MONOCYTES; POISONS; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84893421276     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2013.850506     Document Type: Article

References (48)

1. Olarte RA, Horn BW, Dorner JW, et al. Effect of sexual recombination on population diversity in aflatoxin production by Aspergillus flavus and evidence for cryptic heterokaryosis. Mol Ecol 2012;21:1453-1476.
2. Chang PK, Scharfenstein LL, Mack B, et al. Deletion of the Aspergillus flavus Orthologue of A. nidulans fluG reduces conidiation and promotes production of sclerotia but does not abolish aflatoxin biosynthesis. Appl Environ Microbiol 2012;78: 7557-7563.
3. 1-induced lung tumors from AC3F1 (A/J x C3H/HeJ) mice. Carcinogenesis 1996;17:1735-1740.
4. Villar S, Ortiz-Cuaran S, Abedi-Ardekani B, et al. Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis. PLoS ONE 2012;7:e37707.
5. Josse R, Dumont J, Fautrel A, et al. Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds. Toxicol Appl Pharmacol 2012;258:176-187.
6. 1-induced liver tumors in hepatitis virus C transgenic mice. Int J Cancer 2012;130:1347-1356.
7. Suphakarn VS, Newberne PM, Goldman M. Vitamin A and aflatoxin: effect on liver and colon cancer. Nutr Cancer 1983;5: 41-50.
8. Dimitri RA, Gabal MA. Immunosuppressant activity of aflatoxin ingestion in rabbits measured by response to Mycobacterium bovis antigen I. Cell mediated immune response measured by skin test reaction. Vet Hum Toxicol 1996;38:333-336.
9. Ayed-Boussema I, Pascussi JM, Maurel P, et al. Effect of aflatoxin B1 on nuclear receptors PXR, CAR, and AhR and their target cytochromes P450 mRNA expression in primary cultures of human hepatocytes. Int J Toxicol 2012;31:86-93.
10. Kensler TW, Roebuck BD, Wogan GN, et al. Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol Sci 2011;120 Suppl 1:S28-S48.
11. 1 metabolism in human hepatocytes in primary culture. Cancer Res 1995;55: 5574-5579.
12. Bertilsson G, Heidrich J, Svensson K, et al. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci USA 1998;95: 12208-12213.
13. Kliewer SA, Goodwin B, Willson TM. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 2002;23:687-702.
14. Lehmann JM, McKee DD, Watson MA, et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 1998;102:1016-1023.
15. Pascussi JM, Drocourt L, Fabre JM, et al. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol Pharmacol 2000;58:361-372.
16. Teo YL, Saetaew M, Chanthawong S, et al. Effect of CYP3A4 inducer dexamethasone on hepatotoxicity oflapatinib: clinical and in vitro evidence. Breast Cancer Res Treat 2012;133:703-711.
17. Binkhorst L, van Gelder T, Loos WJ, et al. Effects of CYP induction by rifampicin on tamoxifen exposure. Clin Pharmacol Ther 2012;92:62-67.
18. Sumida A, Fukuen S, Yamamoto I, et al. Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR. Biochem Biophys Res Commun 2000;267:756-760.
19. 1. Toxicol Appl Pharmacol 2000;165:45-52.
20. Vrancic M, Banjanac M, Nujic K, et al. Azithromycin distinctively modulates classical activation of human monocytes in vitro. Br J Pharmacol 2012;165:1348-1360.
21. Baron JM, Zwadlo-Klarwasser G, Jugert F, et al. Cytochrome P450 1B1: a major P450 isoenzyme in human blood monocytes and macrophage subsets. Biochem Pharmacol 1998;56:1105-1110.
22. Krovat BC, Tracy JH, Omiecinski CJ. Fingerprinting of cytochrome P450 and microsomal epoxide hydrolase gene expression in human blood cells. Toxicol Sci 2000;55:352-360.
23. van Duursen MB, Sanderson JT, van den Berg M. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility. Toxicol Sci 2005;85:703-712.
24. Landi MT, Bertazzi PA, Baccarelli A, et al. TCDD-mediated alterations in the AhR-dependent pathway in Seveso, Italy, 20 years after the accident. Carcinogenesis 2003;24:673-680.
25. 1 in rat spleen mononuclear cells. Toxicol 2012; 302:299-307.
26. Mehrzad J, Klein G, Kamphues J, et al. In vitro effects of very low levels of aflatoxin B on free radicals production and bactericidal activity of bovine blood neutrophils. Vet Immunol Immunopathol 2011;141:16-25.
27. Hassan Z, Khan MZ, Khan A, et al. Immunological status of the progeny of breeder hens kept on ochratoxin A (OTA)-and aflatoxin B(1) (AFB(1))-contaminated feeds. J Immunotoxicol 2012;9: 381-391.
28. Malvandi AM, Mehrzad J, Saleh-moghaddam M. Biologically relevant doses of mixed aflatoxins B and G up-regulate MyD88, TLR2, TLR4 and CD14 transcripts in human PBMC. Immunopharmacol Immunotoxicol 2013;35:528-532.
29. Mehrzad J, Zhao X. T lymphocyte proliferative capacity and CD4/CD8 ratio in primiparous and pluriparous lactating cows. J Dairy Res 2008;75:457-465.
30. Nicoletti I, Migliorati G, Pagliacci MC, et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139: 271-279.
31. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:2002-2007.
32. Storvik M, Huuskonen P, Kyllonen T, et al. Aflatoxin B1-a potential endocrine disruptor up-regulates CYP19A1 in JEG-3 cells. Toxicol Lett 2011;202:161-167.
33. 1 induced lacI mutation in liver and kidney of transgenic mice C57BL/6N: effect of phorone. Mutagenesis 1996;11:69-73.
34. 1 in human lung. Carcinogenesis 1996;17:2487-2494.
35. Henderson MC, Miranda CL, Stevens JF, et al. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humuluslupulus. Xenobiotica 2000;30:235-251.
36. 1 in chickens and quail. Poultry Sci 2010;89:2461-2469.
37. Kamdem LK, Meineke I, Gödtel-Armbrust U, et al. Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1. Chem Res Toxicol 2006;19:577-586.
38. Murphy KP, Travers P, Walport M, et al. Janeway's immunobiol-ogy. New York (NY): Garland Science; 2008.
39. Gallagher EP, Kunze KL, Stapleton PL, et al. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol Appl Pharmacol 1996;141:595-606.
40. Jorge-Nebert LF, Jiang Z, Chakraborty R, et al. Analysis of human CYP1A1 and CYP1A2 genes and their shared bidirectional promoter in eight world populations. Hum Mutat 2010;31: 27-40.
41. Siest G, Jeannesson E, Marteau JB, et al. Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects. Drug Metab Dispos 2008;36:182-189.
42. Ratajewski M, Walczak-Drzewiecka A, Salkowska A, et al. Aflatoxins upregulate CYP3A4 mRNA expression in a process that involves the PXR transcription factor. Toxicol Lett 2011;205: 146-153.
43. Nishimura M, Koeda A, Suganuma Y, et al. Comparison of inducibility of CYP1A and CYP3A mRNAs by prototypical inducers in primary cultures of human, cynomolgus monkey, and rat hepatocytes. Drug Metab Pharmacokinet 2007;22: 178-186.
44. VandenHeuvel JP, Clark GC, Kohn MC, et al. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Res 1994;54:62-68.
45. Iber H, Chen Q, Sewer M, et al. Regulation of hepatic cytochrome P450 2C11 by glucocorticoids. Arch Biochem Biophys 1997;345: 305-310.
46. Messina A, Nannelli A, Fiorio R, et al. Expression and inducibility of CYP1A1, 1A2, 1B1 by beta-naphthoflavone and CYP2B22, 3A22, 3A29, 3A46 by rifampicin in the respiratory and olfactory mucosa of pig. Toxicol 2009;260:47-52.
47. Wu Y, Shi X, Liu Y, et al. Histone deacetylase 1 is required for carbamazepine-induced CYP3A4 expression. J Pharm Biomed Anal 2012;58:78-82.
48. Chaytor AC, See MT, Hansen JA, et al. Effects of chronic exposure of diets with reduced concentrations of aflatoxin and deoxyniva-lenol on growth and immune status of pigs. J Anim Sci 2011;89: 124-135.